|
CCNT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.69970000000386E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34269999999093E-06 |
| Normal-vs-Stage2 |
1.486380E-02 |
| Normal-vs-Stage3 |
4.647600E-02 |
| Normal-vs-Stage4 |
1.856180E-01 |
| Stage1-vs-Stage2 |
4.804400E-01 |
| Stage1-vs-Stage3 |
3.013200E-01 |
| Stage1-vs-Stage4 |
8.184800E-01 |
| Stage2-vs-Stage3 |
8.672800E-01 |
| Stage2-vs-Stage4 |
8.952800E-01 |
| Stage3-vs-Stage4 |
8.074400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.51930000000089E-05 |
| Normal-vs-AfricanAmerican |
2.394200E-04 |
| Normal-vs-Asian |
9.250000E-04 |
| Caucasian-vs-AfricanAmerican |
6.209000E-01 |
| Caucasian-vs-Asian |
3.527000E-01 |
| AfricanAmerican-vs-Asian |
3.609600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.70719999990222E-07 |
| Normal-vs-Female |
1.541560E-01 |
| Male-vs-Female |
5.780600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.187600E-04 |
| Normal-vs-Extreme_Weight |
2.67989999969132E-07 |
| Normal-vs-Obese |
2.606300E-02 |
| Normal-vs-Extreme_Obese |
1.235630E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.054000E-01 |
| Normal_Weight-vs-Obese |
2.069200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.700200E-01 |
| Extreme_Weight-vs-Obese |
4.841900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.913600E-01 |
| Obese-vs-Extreme_Obese |
2.223800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.377600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.755200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.52395999999388E-05 |
| Normal-vs-Age(81-100Yrs) |
5.63199999999986E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.056600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.772000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.315350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.618400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.963600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.364400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.77630000000695E-06 |
| Normal-VS-Type2 PRCC |
2.422600E-04 |
| Normal-VS-KIRP CIMP |
8.451400E-01 |
| Normal-VS-Unclassified PRCC |
6.412600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.850000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.826580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.828280E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.859400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.433600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.482400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22979999999762E-05 |
| Normal-vs-N1 |
4.007400E-01 |
| Normal-vs-N2 |
1.184020E-01 |
| N0-vs-N1 |
9.218300E-02 |
| N0-vs-N2 |
6.232000E-01 |
| N1-vs-N2 |
6.705000E-01 |
|
|
